BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
39 results:

  • 1. Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study.
    Zhanghuang C; Zhu J; Li Y; Wang J; Ma J; Li L; Yao Z; Ji F; Wu C; Tang H; Xie Y; Yan B; Yang Z
    BMC Urol; 2024 Jan; 24(1):12. PubMed ID: 38184526
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cumulative incidence of second primary cancers in a large nationwide cohort of Danish cancer survivors: a population-based retrospective cohort study.
    Kjaer TK; Andersen EAW; Ursin G; Larsen SB; Bidstrup PE; Winther JF; Borre M; Johansen C; Dalton SO
    Lancet Oncol; 2024 Jan; 25(1):126-136. PubMed ID: 38048803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive.
    Peng ZH; Tian JH; Chen BH; Zhou HB; Bi H; He MX; Li MR; Zheng XY; Wang YW; Chong T; Li ZL
    Sci Rep; 2023 Oct; 13(1):18424. PubMed ID: 37891423
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
    Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
    World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term Recurrence Rates of Low-risk Non-muscle-invasive Bladder cancer-How Long Is Cystoscopic Surveillance Necessary?
    Ma J; Roumiguie M; Hayashi T; Kohada Y; Zlotta AR; Lévy S; Matsumoto T; Sano T; Black PC
    Eur Urol Focus; 2024 Jan; 10(1):189-196. PubMed ID: 37442722
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: a population-based study.
    Liu L; Li C; Wang Q; Yuan H; Wang Y
    Eur J Med Res; 2023 Feb; 28(1):61. PubMed ID: 36732873
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nomograms and scoring system for forecasting overall and cancer-specific survival of patients with prostate cancer.
    Zhou Y; Lin C; Zhu L; Zhang R; Cheng L; Chang Y
    Cancer Med; 2023 Feb; 12(3):2600-2613. PubMed ID: 35993499
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
    Singh D; Gupta M; Sarwat M; Siddique HR
    Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
    O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
    Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. National cancer Information System Within the Framework of Health Insurance in Colombia: A Real-World Data Approach to Evaluate Access to cancer Care.
    Hernández Vargas JA; Ramírez Barbosa PX; Valbuena-Garcia AM; Acuña-Merchán LA; González-Diaz JA; Lopes G
    JCO Glob Oncol; 2021 Aug; 7():1329-1340. PubMed ID: 34473526
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer Stage, treatment, and Survival Among Transgender Patients in the United States.
    Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
    J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
    Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
    Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of robotic-assisted versus retropubic radical prostatectomy: a single cancer center experience.
    de Oliveira RAR; Guimarães GC; Mourão TC; de Lima Favaretto R; Santana TBM; Lopes A; de Cassio Zequi S
    J Robot Surg; 2021 Dec; 15(6):859-868. PubMed ID: 33417155
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidence of bone metastases in patients with organ-specific cancers: A nationwide population-based cohort study.
    Shih JT; Yeh TT; Wang SH; Shen PH; Wang CC; Chien WC; Chung CH; Wu CC
    Int J Clin Pract; 2021 May; 75(5):e13997. PubMed ID: 33400307
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results.
    Zhang J; Ou Z; Zhang X; He W; Wang R; Mo M; Chen L; Xu R; Jiang S; Peng X; Qi L; Wang L
    World J Urol; 2020 Jun; 38(6):1555-1562. PubMed ID: 31502032
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. cancer treatment and survivorship statistics, 2019.
    Miller KD; Nogueira L; Mariotto AB; Rowland JH; Yabroff KR; Alfano CM; Jemal A; Kramer JL; Siegel RL
    CA Cancer J Clin; 2019 Sep; 69(5):363-385. PubMed ID: 31184787
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels.
    Zhang X; Zhong Y; Saad F; Haider KS; Haider A; Clendenin AG; Xu X
    Aging Male; 2020 Jun; 23(2):112-118. PubMed ID: 30857458
    [No Abstract]    [Full Text] [Related]  

  • 19. Clinically occult prostate cancer cases may distort the effect of testosterone replacement therapy on risk of PCa.
    Zhang X; Zhong Y; Saad F; Haider K; Haider A; Xu X
    World J Urol; 2019 Oct; 37(10):2091-2097. PubMed ID: 30659301
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Estimating the Cost of Illness of prostate cancer in Iran.
    Mojahedian MM; Toroski M; Keshavarz K; Aghili M; Zeyghami S; Nikfar S
    Clin Ther; 2019 Jan; 41(1):50-58. PubMed ID: 30545740
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.